Thank you for sharing!

Your article was successfully shared with the contacts you provided.
Ronald Machen Ronald Machen Jr., former U.S. attorney for D.C. and now a Wilmer Hale partner. Photo: Diego M. Radzinschi/ ALM

The pharmaceutical giant Gilead Sciences Inc. just days ago accused the United States of violating collaboration agreements in a new civil court complaint in Washington that comes as the company is winning praise from the Trump administration for a drug that shows early promise for treating patients suffering from the novel coronavirus.

Gilead’s case in the U.S. Court of Federal Claims, filed by lawyers from Wilmer Cutler Pickering Hale and Dorr, confronts agreements between the United States and Gilead concerning HIV treatment and prevention. The complaint alleged the federal government had asserted “patents that it secretly obtained in violation of the collaboration agreements that Gilead entered into and executed in good faith.”

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]

Mike Scarcella

Mike Scarcella is a senior editor in Washington on ALM Media's regulatory desk. Contact him at [email protected]. On Twitter: @MikeScarcella. Mike works on a slate of newsletters: Supreme Court Brief | Higher Law | Compliance Hot Spots | Labor of Law.

More from this author

Reprints & Licensing
Mentioned in a Law.com story?

License our industry-leading legal content to extend your thought leadership and build your brand.


ALM Legal Publication Newsletters

Sign Up Today and Never Miss Another Story.

As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters. Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss. Tailored just for you. In your inbox. Every day.

Copyright © 2021 ALM Media Properties, LLC. All Rights Reserved.